• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

One-time telephone interventions have little effect on drug abuse

byJohn PrendergassandBrittany Hasty, MD
August 5, 2014
in Chronic Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. No significant difference from baseline drug use was observed in patients who received a thirty minute telephone session of motivational interviewing. 

2. Individuals with a high severity of drug abuse were more likely to enter specialist drug treatment programs and reduce their use of the emergency department.

Evidence Rating Level: 1 (Excellent) 

Study Rundown: In our country, alcohol and drug abuse affects individuals of all socioeconomic classes, cultures, and ages. The physical effects of drug abuse are well known and include liver failure, kidney disease, encephalopathy, and cardiomyopathy, among other systemic conditions. The public health and societal implications of drug abuse, however, are less advertised. These include increased mortality, crime, lost productivity in the workplace, and ever increasing medical care costs. Such consequences of drug abuse affect not only the abuser but the country as a whole.

With this in mind, this study set out to determine if thirty minute telephone interviews concerning an individual’s drug abuse may have an affect of their frequency of use. Patients were recruited from waiting rooms and primary care clinics. Secondary outcomes included inpatient hospitalizations, arrest records, and death rates. Ultimately, no significant decrease in drug use nor secondary outcomes was observed at 3 months after the intervention. A major weakness of the study was the heterogeneity of drug use among its participants, including marijuana, opiates, and stimulants. Another weakness was a high rate of mental illness in the study population. Combined, these aspects of the study greatly hinder reproducibility. While the intervention did not prove workable, it did demonstrate how much more work is needed to affect drug abuse on a grand scale. Future studies should focus on examining the effect of more targeted, aggressive, interventions on those with a high severity of abuse.

Click to read the study, published today in JAMA

Relevant Reading: Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse

RELATED REPORTS

USPSTF Update: Screening adults for unhealthy drug use has moderate net benefit

TAPS tool may help detect clinically relevant substance use in adult primary care patients

AAP opposes school-based drug testing of adolescents

In-Depth [randomized controlled trial]: This 2-group randomized clinical trial consisted of 846 patients recruited between April 2009 and September 2012 from the waiting rooms of hospitals and primary care clinics in Washington. 423 (97%) patients received a brief intervention and 203 (47%) received a booster call. Mean days used of the most common problem drug at baseline were 14.40 (SD,11.29) (brief intervention) and 13.25 (SD, 10.69) (enhanced care as usual). At 3 months postintervention, brief intervention mean was 11.87 (SD, 12.13) and enhances care as usual mean was 9.84 (SD, 10.64). There was no significant difference in either of these groups from baseline (difference in differences, β = 0.89 [95% CI, −0.49 to 2.26]). There was also no significant difference in secondary outcomes from baseline.

Image: CC/Wiki

More from this author: Reducing surgical complications may increase costs,Protected sleep periods improve intern alertness and sleep duration,ADHD medication decreases rates of criminality in ADHD patients,Low dose aspirin shows net clinical benefit in patients with first unprovoked venous thromboembolism, Rare TREM-2 mutation implicated in Alzheimer’s Disease

 ©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: drugs
Previous Post

Immune-modulating enteral nutrition does not reduce infections in the ICU

Next Post

Early alteplase treatment leads to better stroke outcomes regardless of age or stroke severity

RelatedReports

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

USPSTF Update: Screening adults for unhealthy drug use has moderate net benefit

June 11, 2020
Active smoking cessation intervention may provide tangible results [Project CLIQ]
Chronic Disease

TAPS tool may help detect clinically relevant substance use in adult primary care patients

September 6, 2016
AAP opposes school-based drug testing of adolescents
Pediatrics

AAP opposes school-based drug testing of adolescents

March 30, 2015
Study lends support for interferon-free treatment of hepatitis C
Chronic Disease

Maintenance opioids in drug users linked with lower rate of hepatitis C infection

October 28, 2014
Next Post
No obesity paradox found between BMI, stroke, and death

Early alteplase treatment leads to better stroke outcomes regardless of age or stroke severity

Pro-vaccine messages not associated with increased vaccination intent

BCG vaccine protective against active tuberculosis in children

ACP endorses polysomnography over portable monitors for diagnosing sleep apnea

ACP endorses polysomnography over portable monitors for diagnosing sleep apnea

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Synergistic interaction between risk burden and genetics for atrial fibrillation development
  • Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
  • Specific histopathologic renal lesions may be associated with increased risk of cardiovascular disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options